Search Results - "Eliaz, Ran"

Apoptotic cell therapy for cytokine storm associated with acute severe sepsis by Karbian, Netanel, Abutbul, Avraham, el-Amore, Raja, Eliaz, Ran, Beeri, Ronen, Reicher, Barak, Mevorach, Dror

“…Sepsis has no proven pharmacologic treatment other than appropriate antibiotic agents, fluids, vasopressors as needed, and possibly corticosteroids. It is…”
Get full text

The Role Played by Transcription Factor E3 in Modulating Cardiac Hypertrophy by Rishiq, Ahmed, Islam, Omedul, Golomb, Eliahu, Gilon, Dan, Smith, Yoav, Savchenko, Ilya, Eliaz, Ran, Foo, Roger SY, Razin, Ehud, Tshori, Sagi

“…Transcription factor E3 (TFE3), which is a key regulator of cellular adaptation, is expressed in most tissues, including the heart, and is reportedly…”
Get full text

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression by Hirsh Raccah, Bruria, Yanovsky, Alona, Treves, Nir, Rotshild, Victoria, Renoux, Christel, Danenberg, Haim, Eliaz, Ran, Matok, Ilan

“…It has been suggested that lipid lowering therapy causes impaired cognitive changes. The association between the use of Proprotein Convertase Subtilisin/Kexin…”
Get full text

Feasibility and safety of a novel blunt tip concealed needle device for pericardial access in porcine models by Ahmed, Adnan, Garg, Jalaj, Kabra, Rajesh, Charate, Rishi, Eliaz, Ran, Demma, Jonathan Abraham, Menshes, Ziv, Hazan, Or, Lakkireddy, Dhanunjaya

“…Percutaneous pericardial access is the cornerstone of various procedures in clinical cardiology. The two commonly used methods utilizing large bore (LB) and…”
Get full text

Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease by Shuvy, Mony, Abedat, Suzan, Eliaz, Ran, Abu-Rmeileh, Israa, Abu-Snieneh, Asmahan, Ben-Dov, Iddo Z, Meir, Karen, Pereg, David, Beeri, Ronen, Lotan, Chaim

“…High serum levels of phosphate are associated with uremia-induced calcific aortic valve disease (CAVD). However, it is not clear whether hyperphosphatemia is…”
Get more information

Utilization of intra-aortic balloon pump to allow MitraClip procedure in patients with non-coapting mitral valve leaflets: a case series by Eliaz, Ran, Turyan, Anna, Beeri, Ronen, Shuvy, Mony

“…Abstract Background The MitraClip (MC) procedure was designed for high-risk surgical patients with severe mitral regurgitation (MR). Some patients do not meet…”
Get full text

Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Analysis from the Acute Coronary Syndrome Israeli Survey by Eliaz, Ran, Mengesha, Bethlehem, Ovdat, Tal, Iakobishvili, Zaza, Hasdai, David, Kheifets, Mark, Klempfner, Robert, Beigel, Roy, Kalmanovich, Eran, Alcalai, Ronny, Levi, Amos

“…We aimed to compare the outcomes of acute coronary syndrome (ACS) patients undergoing in-hospital percutaneous coronary intervention treated with prasugrel…”
Get more information

Long-Term Prognosis in Young Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention by Yagel, Oren, Shadafny, Naseem, Eliaz, Ran, Dagan, Gil, Leibowitz, David, Tahiroglu, Ilgar, Planer, David, Amir, Offer, Elbaz Greener, Gabby, Alcalai, Ronny

“…Acute coronary syndrome (ACS) at a young age is uncommon. Limited data regarding the long-term follow-up and prognosis in this population are available. Our…”
Get full text